<DOC>
	<DOCNO>NCT02932501</DOCNO>
	<brief_summary>Approximately 500 patient include patient registry . Data collection include demographic , clinical data underlie disease use bisphosphonates , denosumab antiangiogenic drug , degree extension osteonecrosis , osteonecrosis-specific treatment , outcomes complication within 1 year treatment .</brief_summary>
	<brief_title>Medication-related Osteonecrosis Jaw ( MRONJ ) Registry</brief_title>
	<detailed_description>Approximately 500 patient diagnose medication-related osteonecrosis jaw enrol study . Patients undergo standard ( routine ) care treatment , either conservative surgical , follow one year initiation treatment . Treatment outcome ( development condition ) , pain complication collect documented duration registry .</detailed_description>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Bisphosphonate-Associated Osteonecrosis Jaw</mesh_term>
	<criteria>Age &gt; 18 year Newly diagnose patient osteonecrosis facial bone jaw , Newly diagnose patient nonexposed MRONJ ( stage 0 ) , Newly diagnose patient expose MRONJ , i.e : Current previous treatment antiresorptive antiangiogenic agent . Exposed bone bone probe intraoral extraoral fistula ( e ) maxillofacial region persist 8 week No history radiation therapy jaw obvious metastatic disease jaw Ability understand content patient information/ Informed Consent Form Willingness ability participate clinical investigation accord Registry Plan ( RP ) Signed date IRB/ECapproved write informed consent Mental capacity comply postoperative regimen , evaluation data collection Recent history substance abuse ( i. e. , recreational drug , alcohol ) would preclude reliable assessment Pregnancy woman plan conceive within registry period Prisoner Participation medical device medicinal product study within previous month could influence result present registry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Bisphosphonate</keyword>
	<keyword>Jaw</keyword>
	<keyword>Osteonecrosis</keyword>
	<keyword>Antiresorptive drug</keyword>
	<keyword>Denosumab</keyword>
</DOC>